555 related articles for article (PubMed ID: 25140956)
1. Controlled trial of transfusions for silent cerebral infarcts in sickle cell anemia.
DeBaun MR; Gordon M; McKinstry RC; Noetzel MJ; White DA; Sarnaik SA; Meier ER; Howard TH; Majumdar S; Inusa BP; Telfer PT; Kirby-Allen M; McCavit TL; Kamdem A; Airewele G; Woods GM; Berman B; Panepinto JA; Fuh BR; Kwiatkowski JL; King AA; Fixler JM; Rhodes MM; Thompson AA; Heiny ME; Redding-Lallinger RC; Kirkham FJ; Dixon N; Gonzalez CE; Kalinyak KA; Quinn CT; Strouse JJ; Miller JP; Lehmann H; Kraut MA; Ball WS; Hirtz D; Casella JF
N Engl J Med; 2014 Aug; 371(8):699-710. PubMed ID: 25140956
[TBL] [Abstract][Full Text] [Related]
2. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Kimber C; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD012389. PubMed ID: 32250453
[TBL] [Abstract][Full Text] [Related]
3. Interventions for preventing silent cerebral infarcts in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Doree C; Abboud MR
Cochrane Database Syst Rev; 2017 May; 5(5):CD012389. PubMed ID: 28500860
[TBL] [Abstract][Full Text] [Related]
4. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Kohli R; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD003146. PubMed ID: 32716555
[TBL] [Abstract][Full Text] [Related]
5. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Wang WC
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD003146. PubMed ID: 28094851
[TBL] [Abstract][Full Text] [Related]
6. Blood transfusion therapy is feasible in a clinical trial setting in children with sickle cell disease and silent cerebral infarcts.
King AA; Noetzel M; White DA; McKinstry RC; Debaun MR
Pediatr Blood Cancer; 2008 Mar; 50(3):599-602. PubMed ID: 17985350
[TBL] [Abstract][Full Text] [Related]
7. Silent cerebral infarcts occur despite regular blood transfusion therapy after first strokes in children with sickle cell disease.
Hulbert ML; McKinstry RC; Lacey JL; Moran CJ; Panepinto JA; Thompson AA; Sarnaik SA; Woods GM; Casella JF; Inusa B; Howard J; Kirkham FJ; Anie KA; Mullin JE; Ichord R; Noetzel M; Yan Y; Rodeghier M; Debaun MR
Blood; 2011 Jan; 117(3):772-9. PubMed ID: 20940417
[TBL] [Abstract][Full Text] [Related]
8. Silent infarcts in children with sickle cell anemia and abnormal cerebral artery velocity.
Pegelow CH; Wang W; Granger S; Hsu LL; Vichinsky E; Moser FG; Bello J; Zimmerman RA; Adams RJ; Brambilla D;
Arch Neurol; 2001 Dec; 58(12):2017-21. PubMed ID: 11735775
[TBL] [Abstract][Full Text] [Related]
9. Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography.
Adams RJ; McKie VC; Hsu L; Files B; Vichinsky E; Pegelow C; Abboud M; Gallagher D; Kutlar A; Nichols FT; Bonds DR; Brambilla D
N Engl J Med; 1998 Jul; 339(1):5-11. PubMed ID: 9647873
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of regular transfusions for cerebral infarct recurrence in the Silent Cerebral Infarct Transfusion Trial.
Hsu P; Gay JC; Lin CJ; Rodeghier M; DeBaun MR; Cronin RM
Blood Adv; 2021 Dec; 5(23):5032-5040. PubMed ID: 34607344
[TBL] [Abstract][Full Text] [Related]
11. Stroke prevention trial in sickle cell anemia.
Adams RJ; McKie VC; Brambilla D; Carl E; Gallagher D; Nichols FT; Roach S; Abboud M; Berman B; Driscoll C; Files B; Hsu L; Hurlet A; Miller S; Olivieri N; Pegelow C; Scher C; Vichinsky E; Wang W; Woods G; Kutlar A; Wright E; Hagner S; Tighe F; Waclawiw MA
Control Clin Trials; 1998 Feb; 19(1):110-29. PubMed ID: 9492971
[TBL] [Abstract][Full Text] [Related]
12. Intracranial vasculopathy and infarct recurrence in children with sickle cell anaemia, silent cerebral infarcts and normal transcranial Doppler velocities.
Choudhury NA; DeBaun MR; Ponisio MR; Jordan LC; Rodeghier M; Pruthi S; McKinstry RC
Br J Haematol; 2018 Oct; 183(2):324-326. PubMed ID: 29076125
[TBL] [Abstract][Full Text] [Related]
13. Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease.
Pegelow CH; Macklin EA; Moser FG; Wang WC; Bello JA; Miller ST; Vichinsky EP; DeBaun MR; Guarini L; Zimmerman RA; Younkin DP; Gallagher DM; Kinney TR
Blood; 2002 Apr; 99(8):3014-8. PubMed ID: 11929794
[TBL] [Abstract][Full Text] [Related]
14. Reduction in Overt and Silent Stroke Recurrence Rate Following Cerebral Revascularization Surgery in Children with Sickle Cell Disease and Severe Cerebral Vasculopathy.
Hall EM; Leonard J; Smith JL; Guilliams KP; Binkley M; Fallon RJ; Hulbert ML
Pediatr Blood Cancer; 2016 Aug; 63(8):1431-7. PubMed ID: 27106860
[TBL] [Abstract][Full Text] [Related]
15. Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction.
Dowling MM; Noetzel MJ; Rodeghier MJ; Quinn CT; Hirtz DG; Ichord RN; Kwiatkowski JL; Roach ES; Kirkham FJ; Casella JF; DeBaun MR
J Pediatr; 2014 May; 164(5):1175-1180.e1. PubMed ID: 24529619
[TBL] [Abstract][Full Text] [Related]
16. Blood transfusion for preventing primary and secondary stroke in people with sickle cell disease.
Wang WC; Dwan K
Cochrane Database Syst Rev; 2013 Nov; (11):CD003146. PubMed ID: 24226646
[TBL] [Abstract][Full Text] [Related]
17. Associated risk factors for silent cerebral infarcts in sickle cell anemia: low baseline hemoglobin, sex, and relative high systolic blood pressure.
DeBaun MR; Sarnaik SA; Rodeghier MJ; Minniti CP; Howard TH; Iyer RV; Inusa B; Telfer PT; Kirby-Allen M; Quinn CT; Bernaudin F; Airewele G; Woods GM; Panepinto JA; Fuh B; Kwiatkowski JK; King AA; Rhodes MM; Thompson AA; Heiny ME; Redding-Lallinger RC; Kirkham FJ; Sabio H; Gonzalez CE; Saccente SL; Kalinyak KA; Strouse JJ; Fixler JM; Gordon MO; Miller JP; Noetzel MJ; Ichord RN; Casella JF
Blood; 2012 Apr; 119(16):3684-90. PubMed ID: 22096242
[TBL] [Abstract][Full Text] [Related]
18. Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes.
Jordan LC; Roberts Williams DO; Rodeghier MJ; Covert Greene BV; Ponisio MR; Casella JF; McKinstry RC; Noetzel MJ; Kirkham FJ; Meier ER; Fuh B; McNaull M; Sarnaik S; Majumdar S; McCavit TL; DeBaun MR
Am J Hematol; 2018 Jun; 93(6):760-768. PubMed ID: 29520844
[TBL] [Abstract][Full Text] [Related]
19. Automated exchange compared to manual and simple blood transfusion attenuates rise in ferritin level after 1 year of regular blood transfusion therapy in chronically transfused children with sickle cell disease.
Kelly S; Rodeghier M; DeBaun MR
Transfusion; 2020 Nov; 60(11):2508-2516. PubMed ID: 32812667
[TBL] [Abstract][Full Text] [Related]
20. Design of the silent cerebral infarct transfusion (SIT) trial.
Casella JF; King AA; Barton B; White DA; Noetzel MJ; Ichord RN; Terrill C; Hirtz D; McKinstry RC; Strouse JJ; Howard TH; Coates TD; Minniti CP; Campbell AD; Vendt BA; Lehmann H; Debaun MR
Pediatr Hematol Oncol; 2010 Mar; 27(2):69-89. PubMed ID: 20201689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
